FindTrial
Sign In

Impact of Medication Therapy Management for Chronic Kidney Disease Patients

Assessment of Medication Therapy Management on Health-Related Quality of Life, Medication Adherence and Pharmacoeconomic Evaluation of Chronic Kidney Disease Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035807
Enrollment
220
Registered
2021-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

Intervention1: Medication Therapy Management group: Medication Therapy Management (MTM) group will receive the clinical pharmacists MTM services along with usual care provided by hospital team such as

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged above 18 years. Both male and female who are diagnosed with chronic kidney disease not on dialysis. Both inpatients and outpatients.

Exclusion criteria

Exclusion criteria: Patients who are having psychiatric, other terminal illnesses and cognitive impairments. Pregnant and lactating women. Patients who are receiving hemodialysis and peritoneal dialysis. Patients who underwent kidney transplantation surgery.

Design outcomes

Primary

MeasureTime frame
Health-Related QualityTimepoint: Base line, 6th month and 12th month.—

Secondary

MeasureTime frame
Clinical, Economic and Medication AdherenceTimepoint: Base line, 6th month and 12th month.—

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

K. S. Hegde Medical Academy, Justice KS Hegde Charitable Hospital

mpradeepshenoy@gmail.com9844546066

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026